| 英文名称 | 中文名称 | CAS | MF |
|
4,4'-(1,5-dihydrobenzo[1,2-d:4,5-d']diimidazole-2,6-diyl)dibenzonitrile
|
4,4-(1,5-二氢苯并[1,2-D:4,5-D]二咪唑-2,6-二基)二苄腈
|
2247996-19-4
|
C22H12N6
|
|
AZD3229
|
化合物AZD3229
|
2248003-60-1
|
C24H26FN7O3
|
|
AZD3229 Tosylate
|
AZD3229 Tosylate
|
2248003-71-4
|
C31H34FN7O6S
|
|
tert-Butyl (4-((5-fluoro-7-(2-methoxyethoxy)quinazolin-4-yl)amino)phenyl)carbamate
|
叔丁基(4-((5-氟-7-(2-甲氧基乙氧基)喹唑啉-4-基)氨基)苯基)氨基甲酸酯
|
2248003-87-2
|
C22H25FN4O4
|
|
2H-1,4-Benzoxazin-3(4H)-one, 8-[(1R)-2-bromo-1-hydroxyethyl]-6-(phenylmethoxy)-
|
奥达特罗杂质21
|
2248125-51-9
|
C17H16BrNO4
|
|
4,6-bis(2-ethylhexyl)benzo[1,2-b:6,5-b':3,4-c'']trithiophene
|
4,6-bis(2-ethylhexyl)benzo[1,2-b:6,5-b':3,4-c'']trithiophene
|
2248149-78-0
|
C28H38S3
|
|
7-fluoro-6-methoxy-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)quinoline
|
7-fluoro-6-methoxy-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)quinoline
|
2248157-24-4
|
C16H19BFNO3
|
|
Ethyl 5-(5-bromothiophen-2-yl)-1H-pyrazole-3-carboxylate
|
Ethyl 5-(5-bromothiophen-2-yl)-1H-pyrazole-3-carboxylate
|
2248181-61-3
|
C10H9BrN2O2S
|
|
(2S)-2-(4,4-difluorocyclohexyl)-2-(9H-fluoren-9-ylmethoxycarbonylamino)acetic acid
|
(2S)-2-(4,4-difluorocyclohexyl)-2-(9H-fluoren-9-ylmethoxycarbonylamino)acetic acid
|
2248184-59-8
|
C23H23F2NO4
|
|
mPEG24-acid
|
mPEG24-acid
|
2248203-61-2
|
C50H100O26
|
|
2,4(1H,3H)-Quinazolinedione, 7-bromo-6,8-difluoro-
|
7-溴-6,8-二氟喹唑啉-2,4(1H,3H)-二酮
|
2248301-65-5
|
C8H3BrF2N2O2
|
|
7-bromo-2,4-dichloro-6,8-difluoroquinazoline
|
7-溴-2,4-二氯-6,8-二氟喹唑啉
|
2248318-27-4
|
C8HBrCl2F2N2
|
|
2-(difluoromethyl)-5-fluorobenzoic acid
|
2-(二氟甲基)-5-氟苯甲酸
|
2248349-16-6
|
C8H5F3O2
|
|
7,7-difluorobicyclo[4.1.0]heptane-1-carboxylic acid
|
7,7-difluorobicyclo[4.1.0]heptane-1-carboxylic acid
|
2248351-67-7
|
C8H10F2O2
|
|
1,3-Butanedione, 1-(4-morpholinyl)-4-(2,4,5-trifluorophenyl)-
|
西他列汀杂质83
|
2248445-00-1
|
C14H14F3NO3
|
|
4,4',4'',4'''-(Ethene-1,1,2,2-tetrayl)tetrakis(benzene-1,2-diol)
|
四(3,4-二羟苯基)乙烯
|
2248462-00-0
|
C26H20O8
|
|
Ticagrelor Imp.J
|
Ticagrelor Imp.J
|
2248538-63-6
|
C14H20ClN5O4S
|
|
potassium trifluoro({[4-(trifluoromethyl)phenyl]methyl})boranuide
|
三氟({[4-(三氟甲基)苯基]甲基})硼酸钾
|
2248620-16-6
|
C8H5BF6K
|
|
potassium trifluoro(2-(trifluoromethyl)benzyl)borate
|
(2-(三氟甲基)苄基)三氟硼酸钾
|
2248620-18-8
|
C8H5BF6K
|
|
Elagolix Sodium impurity4
|
Elagolix Sodium impurity4
|
2248628-92-2
|
C19H21NO4S
|
|
(R)-5-(2-fluoro-3-methoxyphenyl)-1-(2-fluoro-6-(trifluoromethyl)benzyl)-6-methyl-3-(2-(2-oxopyrrolidin-1-yl)-2-phenylethyl)pyrimidine-2,4(1H,3H)-dione
|
(R)-5-(2-FLUORO-3-METHOXYPHENYL)-1-(2-FLUORO-6-(TRIFLUOROMETHYL)BENZYL)-6-METHYL-3-(2-(2-OXOPYRROLID
|
2248628-93-3
|
C32H28F5N3O4
|
|
1,3,2-Dioxaborolane, 2,2'-(2,2'-dichloro[1,1'-biphenyl]-3,3'-diyl)bis[4,4,5,5-tetramethyl-
|
2,2'-二氯联苯-3,3'-双硼酸频哪醇酯
|
2248640-53-9
|
C24H30B2Cl2O4
|
|
(S)-5-Aminomethyl-pyrrolidin-2-one hydrochloride
|
(S)-5-氨基甲基吡咯烷-2-酮盐酸盐
|
2248666-06-8
|
C5H11ClN2O
|
|
PF429242 dihydrochloride
|
PF429242 DIHYDROCHLORIDE
|
2248666-66-0
|
C25H36ClN3O2
|
|
2,6-Piperidinedione, 3-[6-(aminomethyl)-1,3-dihydro-1-oxo-2H-isoindol-2-yl]-, hydrochloride (1:1)
|
3-(6-(氨甲基)-1-氧代异吲哚啉-2-基)哌啶-2,6-二酮盐酸盐
|
2248702-12-5
|
C14H16ClN3O3
|
|
N-(tert-butyl)-2-(pyridin-4-yl)-1,7-naphthyridin-4-amine
|
N-(叔丁基)-2-(吡啶-4-基)-1,7-萘啶-4-胺
|
2248729-26-0
|
C17H18N4
|
|
Cis-2-Methylcyclopentanamine Hydrochloride
|
(1S,2R)-2-甲基环戊烷-1-胺盐酸盐
|
2248730-49-4
|
C6H13N.ClH
|
|
N6-Benzoyl-9-(2'-deoxy-5'-O-DMT-2'-fluoro-b-D-arabinofuranosyl)adenine 3'-CE phosphoramidite
|
N6-Benzoyl-9-(2'-deoxy-5'-O-DMT-2'-fluoro-b-D-arabinofuranosyl)adenine 3'-CE phosphoramidite
|
2248740-48-7
|
C47H51FN7O7P
|
|
2-Propanol, 1-(9H-carbazol-4-yloxy)-3-[[2-(2-methoxyphenoxy)ethyl]nitrosoamino]-
|
卡维地洛杂质17
|
2248746-67-8
|
C24H25N3O5
|
|
(S)-3-(2,6-Diethylphenyl)-1-(1-hydroxy-3-methylbutan-2-yl)-4,5-dihydro-1H-imidazol-3-ium hexafluorophosphate(V)
|
(S)-3-(2,6-二乙基苯基)-1-(1-羟基-3-甲基丁-2-基)-4,5-二氢-1H-咪唑-3-鎓六氟磷酸盐(V)
|
2248771-38-0
|
C18H29F6N2OP
|
|
(S)-3-(2,6-Diisopropylphenyl)-1-(2-hydroxy-1-phenylethyl)-4,5-dihydro-1H-imidazol-3-ium hexafluorophosphate(V)
|
(S)-3-(2,6-二异丙基苯基)-1-(2-羟基-1-苯基乙基)-4,5-二氢-1H-咪唑-3-六氟磷酸盐(V)
|
2248771-39-1
|
C23H31F6N2OP
|
|
1-((1S,2R)-2-Hydroxy-2,3-dihydro-1H-inden-1-yl)-3-mesityl-4,5-dihydro-1H-imidazol-3-ium hexafluorophosphate(V)
|
1-(1S,2R)-2-羟基-2,3-二氢-1H-茚-1-基)-3-均三甲基-4,5-二氢-1H-咪唑-3-六氟磷酸盐(V)
|
2248771-41-5
|
C21H25F6N2OP
|
|
[1,1'-Biphenyl]-4-carboxamide, N-[3-[[(4-fluorophenyl)sulfonyl]amino]-4-hydroxyphenyl]-
|
N-(3-(4-氟苯基磺酰氨基)-4-羟基苯基)-[1,1'-联苯]-4-甲酰胺
|
2249435-90-1
|
C25H19FN2O4S
|
|
(S)-N-[2-(Diphenylphosphino)-1-[2-(diphenylphosphino)phenyl]ethyl]-3,5-bis(trifluoromethyl)benzamide
|
N-[(1S)-2-(二苯基膦)-1-((2-二苯基膦)苯基)乙基]-3,5-二(三氟甲基)苯甲酰胺
|
2249744-81-6
|
C41H31F6NOP2
|
|
PROTAC MDM2 Degrader-3
|
PROTAC MDM2 Degrader-3
|
2249750-23-8
|
C72H78Cl4N8O15
|
|
PROTAC MDM2 Degrader-4
|
PROTAC MDM2 Degrader-4
|
2249750-24-9
|
C70H74Cl4N8O14
|
|
2',2",2"',5',5",5"'-hexamethyl-[1,1':4',1":4",1'":4'",1""-quinquephenyl]-4,4""-dicarboxylic acid
|
2',2“,2”',5',5“,5”'-六甲基-[1,1':4',1“:4”,1'“:4'”,1“”-五苯基]-4,4“”-二羧酸
|
2249751-97-9
|
C38H34O4
|
|
MD2-TLR4-IN-1
|
MD2-TLR4-IN-1
|
2249801-12-3
|
C22H14Cl2N4O
|
|
5'-(1H-tetrazol-5-yl)-[1,1':3',1''-terphenyl]-3,3'',5,5''-tetracarboxylic acid
|
5'-(1H-tetrazol-5-yl)-[1,1':3',1''-terphenyl]-3,3'',5,5''-tetracarboxylic acid
|
2249811-47-8
|
C23H14N4O8
|
|
Dolutegravir-d5
|
DOLUTEGRAVIR-D5
|
2249814-82-0
|
C20H14D5F2N3O5
|
|
2H-Pyran, tetrahydro-4-[(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)methyl]-
|
4,4,5,5-四甲基-2-(四氢吡喃-4-基甲基)-1,3,2-二氧杂硼环戊烷
|
2249826-22-8
|
C12H23BO3
|
|
9,9-Dimethyl-9H-fluoren-4-amine
|
9,9-二甲基-9H-芴-4-胺
|
2249831-75-0
|
C15H15N
|
|
Pyridine, 5-methyl-2-(2-propen-1-ylsulfonyl)-
|
2-(烯丙基磺酰基)-5-甲基吡啶
|
2249891-88-9
|
C9H11NO2S
|
|
2-(Allylsulfonyl)-4-methylpyridine
|
2-(烯丙基磺酰基)-4-甲基吡啶
|
2249891-89-0
|
C9H11NO2S
|
|
2-(Allylsulfonyl)-3-methylpyridine
|
2-(烯丙基磺酰基)-3-甲基吡啶
|
2249891-90-3
|
C9H11NO2S
|
|
Dapoxetine Impurity 15
|
达泊西汀杂质72
|
2249892-52-0
|
C18H18O3
|
|
D-Xylopyranose, 2,3,4-tris-O-(phenylmethyl)-
|
2,3,4-三-O-苄基-D-吡喃糖
|
2249922-12-9
|
C26H28O5
|
|
(S)-3,3'-Bis(2-naphthyl)-5,5',6,6',7,7',8,8'-octahydro-1,1'-binaphthyl-2,2'-diyl Hydrogen Phosphate
|
(S)-3,3'-双(2-萘基)-5,5',6,6',7,7',8,8'-八氢-1,1'-联萘酚磷酸酯
|
2249931-95-9
|
C40H33O4P
|
|
Mal-PEG1-Val-Cit-PAB-PNP
|
马来酰亚胺-一聚乙二醇-VAL-CIT-PAB-PNP 酯
|
2249935-92-8
|
C34H41N7O12
|
|
PROTAC MDM2 Degrader-1
|
PROTAC MDM2 Degrader-1
|
2249944-98-5
|
C74H84Cl4N10O13
|
|
PROTAC MDM2 Degrader-2
|
PROTAC MDM2 Degrader-2
|
2249944-99-6
|
C70H76Cl4N10O12
|
|
[S(R)]-N-[(R)-[2-(Diadamantanphosphino)phenyl]-1-naphthalenylmethyl]-2-methyl-2-propanesulfinamide
|
[S(R)]-N-[(R)-[2-(二金刚烷基膦)苯基]-1-萘基甲基]-2-叔丁基亚磺酰胺
|
2249950-31-8
|
C41H52NOPS
|
|
S(R)]-N-[(R)-[2-(Diadamantanphosphino)phenyl](2-naphthalenyl)methyl]-2-methyl-2-propanesulfinamide
|
S(R)]-N-[(R)-[2-(二金刚烷基膦)苯基](2-萘基)甲基]-2-叔丁基亚磺酰胺
|
2249950-36-3
|
C41H52NOPS
|
|
[S(R)]-N-[(S)-[2-(Diadamantanphosphino)phenyl](2-naphthalenyl)methyl]-2-methyl-2-propanesulfinamide
|
S(R)]-N-[(S)-[2-(二金刚烷基膦)苯基](2-萘基)甲基]-2-叔丁基亚磺酰胺
|
2249950-37-4
|
C41H52NOPS
|
|
Kira8 Hydrochloride
|
KIRA8 HYDROCHLORIDE (AMG-18 HYDROCHLORIDE)
|
2250019-92-0
|
C31H29ClN6O3S.ClH
|
|
Nor NOHA Monoacetate
|
Nor NOHA Monoacetate
|
2250019-93-1
|
C5H12N4O3.C2H4O2
|
|
AR-C 141990 hydrochloride
|
AR-C141990 HYDROCHLORIDE
|
2250019-94-2
|
C26H29ClN4O4S
|
|
Ethyl 4-Bromo-5-chloro-1H-benzimidazole-2-carboxylate
|
4-溴-5-氯-1H-苯并咪唑-2-甲酸乙酯
|
2250023-38-0
|
C10H8BrClN2O2
|
|
N-(2-(2-(2-(4-(4-((5-Chloro-4-((2-(isopropylsulfonyl)phenyl)amino)pyrimidin-2-yl)amino)phenyl)piperazin-1-yl)ethoxy)ethoxy)ethyl)-2-((2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindolin-4-yl)amino)acetamide
|
TL 12-186,多激酶降解PROTAC
|
2250025-88-6
|
C44H51ClN10O9S
|
|
UK 59811 hydrochloride
|
UK 59811 hydrochloride
|
2250025-89-7
|
C22H30BrClN2O5
|
|
DREADD agonist 21 dihydrochloride
|
化合物 T11095
|
2250025-92-2
|
C17H19ClN4
|
|
8-Chloro-11-(4-methyl-4-oxido-1-piperazinyl)-5H-dibenzo[b,e][1,4]diazepine dihydrochloride
|
氯氮平N-氧化盐酸;氯氮平N-氧化物二盐酸盐
|
2250025-93-3
|
C18H21Cl3N4O-
|
|
D-Phenylalanine, 4-[[[(9H-fluoren-9-ylmethoxy)carbonyl]amino]methyl]-N-[(2-propen-1-yloxy)carbonyl]-
|
|
2250029-23-1
|
C29H28N2O6
|
|
tert-butyl (S)-4-((benzyloxy)methyl)-1,2,3-oxathiazolidine-3-carboxylate 2,2-dioxide
|
(S)-4-((苄氧基)甲基)-1,2,3-氧杂噻唑烷-3-羧酸叔丁酯 2,2-二氧化物
|
2250039-78-0
|
C15H21NO6S
|
|
2-(3',5'-Difluoro-[1,1'-biphenyl]-4-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane
|
2-(3',5'-二氟-[1,1'-联苯]-4-基)-4,4,5,5-四甲基-1,3,2-二氧杂硼戊烷
|
2250042-17-0
|
C18H19BF2O2
|
|
H2N-PEG8-CH2COOH
|
氨基-八聚乙二醇-乙酸
|
2250056-24-5
|
C18H37NO10
|
|
CH2COOH-PEG9-CH2COOH
|
CH2COOH-PEG9-CH2COOH
|
2250056-46-1
|
C22H42O14
|
|
HO-PEG10-CH2COOH
|
HO-PEG10-CH2COOH
|
2250056-53-0
|
C22H44O13
|
|
MS645
|
MS645
|
2250091-96-2
|
C48H54Cl2N10O2S2
|
|
2H-Tertrazol2-2-ethanol,
|
2H-TERTRAZOL-2-ETHANOL
|
2250138-81-7
|
C16H14F3N5O
|
|
Nicorandil DiMer
|
尼可地尔杂质06
|
2250142-70-0
|
C16H18N5O5+
|
|
Nicorandil Impurity 18 (Nicorandil Dimer Bromide)
|
尼可地尔杂质18
|
2250142-73-3
|
C16H18BrN5O5
|
|
10-[4-[4,6-Di(adamantan-1-yl)-1,3,5-triazin-2-yl]phenyl]-9,9-dimethyl-9,10-dihydroacridine
|
(PURIFIED BY SUBLIMATION)
|
2250187-15-4
|
C44H48N4
|
|
10-[4-[4,6-Di(1-adamantyl)-1,3,5-triazin-2-yl]phenyl]-10H-spiro[acridine-9,9'-fluorene
|
(PURIFIED BY SUBLIMATION)
|
2250187-16-5
|
C54H50N4
|
|
10-[4-[4,6-Di(adamantan-1-yl)-1,3,5-triazin-2-yl]phenyl]-9,9-diphenyl-9,10-dihydroacridine
|
(PURIFIED BY SUBLIMATION)
|
2250187-17-6
|
C54H52N4
|
|
Mal-PEG5-COOtBu
|
马来酰亚胺-五聚乙二醇-丙酸叔丁酯
|
2250216-91-0
|
C21H35NO9
|
|
Propargyl-PEG3-triethoxysilane
|
Propargyl-PEG3-triethoxysilane
|
2250216-92-1
|
C19H37NO7Si
|
|
BocNH-PEG3-CH2CH2COONHS
|
BocNH-PEG3-CH2CH2COONHS
|
2250216-93-2
|
C18H30N2O9
|
|
Boc-Aminooxy-PEG5-amine
|
Boc-Aminooxy-PEG5-amine
|
2250216-94-3
|
C17H36N2O8
|
|
t-Boc-Aminooxy-PEG5-azide
|
t-Boc-Aminooxy-PEG5-azide
|
2250216-95-4
|
C17H34N4O8
|
|
DBCO-PEG2-amine
|
DBCO-PEG2-amine
|
2250216-96-5
|
C25H29N3O4
|
|
[1,1':3',1''-Terphenyl]-4,4''-diamine, 5'-(4-amino-3,5-diethylphenyl)-3,3'',5,5''-tetraethyl-
|
[1,1':3',1''-Terphenyl]-4,4''-diamine, 5'-(4-amino-3,5-diethylphenyl)-3,3'',5,5''-tetraethyl-
|
2250216-97-6
|
C36H45N3
|
|
Ezetimibe Impurity 72
|
依折麦布杂质72
|
2250240-87-8
|
C24H22FNO2
|
|
Tofacitinib Impurity 36
|
托法替尼杂质36
|
2250241-69-9
|
C13H11N3O3S
|
|
(1R)-1-(3-Methyl(2-pyridyl))ethylamine dihydrochloride
|
(R)-1-(3-甲基吡啶-2-基)乙胺二盐酸盐
|
2250241-76-8
|
C8H13ClN2
|
|
3-chloro-7-methyl-1,6-naphthyridine
|
3-chloro-7-methyl-1,6-naphthyridine
|
2250241-77-9
|
C9H7ClN2
|
|
7-chloropyrrolo[1,2-a]pyrazine-3-carboxylic acid
|
7-氯吡咯并[1,2-A]吡嗪-3-羧酸
|
2250241-78-0
|
C8H5ClN2O2
|
|
2-Amino-2-(4-methylphenyl)ethan-1-ol HCl
|
2-AMINO-2-(4-METHYLPHENYL)ETHAN-1-OL HCL
|
2250241-81-5
|
C9H14ClNO
|
|
cis-2-aminocyclopentane-1-carbonitrile trifluoroacetate
|
2,2,2-三氟乙酸
|
2250241-85-9
|
C8H11F3N2O2
|
|
(1S)-7-Chloro-1,2,3,4-tetrahydronaphthylamine HCl
|
(S)-7-氯-1,2,3,4-四氢萘-1-胺盐酸盐
|
2250241-96-2
|
C10H13Cl2N
|
|
2-Bromo-5,6,7,8-tetrahydroimidazo[1,2-a]pyrazine 2HCl
|
2-溴-5,6,7,8-四氢咪唑并[1,2-A]吡嗪二盐酸盐
|
2250242-00-1
|
C6H9BrClN3
|
|
AmBroxol Impurity 9
|
AmBroxol Impurity 9
|
2250242-11-4
|
C13H18Br2N2O2
|
|
Avanafil Impurity 17
|
Avanafil Impurity 17
|
2250242-12-5
|
C20H26N4O4
|
|
Lamotrigine Impurity I
|
Lamotrigine Impurity I
|
2250242-15-8
|
C16H9Cl4N5O
|
|
Carbamic acid, N-[(3R,4S)-3-methoxy-4-piperidinyl]-, 1,1-dimethylethyl ester, ethanedioate (2:1), rel-
|
N-[顺-3-甲氧基哌啶-4-基]氨基甲酸叔丁酯半草酸盐酯
|
2250242-17-0
|
C11H22N2O3.1/2C2H2O4
|
|
Aripiprazole Impurity 35
|
布瑞哌唑杂质5
|
2250242-22-7
|
C28H34N4S2
|
|
Lamivudine Impurity 13
|
Lamivudine Impurity 13
|
2250242-24-9
|
C8H11N3O5S
|
|
(2S)-2-Amino-2-(4-pyridyl)ethan-1-ol dihydrochloride
|
(2S)-2-AMINO-2-(4-PYRIDYL)ETHAN-1-OL DIHYDROCHLORIDE
|
2250242-33-0
|
C7H11ClN2O
|
|
(2S)-2-(3,5-Difluorophenyl)pyrrolidine hydrochloride
|
(2S)-2-(3,5-DIFLUOROPHENYL)PYRROLIDINE HYDROCHLORIDE
|
2250242-36-3
|
C10H12ClF2N
|
|
2-(2-Bromo-6-chlorophenyl)pyrrolidine hydrochloride
|
2250242-40-9
|
2250242-40-9
|
C10H12BrCl2N
|